Presentation TCT 2021 Prosthetic Valve Selection and Implant Techniques for Prevention of PPM/High Residual Gradients Following SAVR, TAVR, or Valve-in-Valve Presenter: David Wood November 06, 2021
News Conference News TCT 2021 TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3 Yael L. Maxwell November 05, 2021
Presentation TCT 2021 PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk Presenter: David Cohen November 05, 2021
News Conference News TCT 2021 SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years Todd Neale November 05, 2021
Presentation TCT 2021 SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk Presenter: Nicolas Van Mieghem November 05, 2021
Presentation TCT 2021 Case Presentation: 75-Year-Old With Severe AS And Proximal LAD Stenosis - TAVI Alone, TAVI Plus PCI or SAVR Plus CABG? Presenter: Yousif Ahmad November 04, 2021
Presentation TCT 2021 Case Presentation: 65-Year-Old With Severe AS And Bicuspid Valve - SAVR or TAVI? Presenter: Karim Al-Azizi November 04, 2021
Presentation TCT 2021 Bioprosthetic Valve Failure: Redo SAVR or ViV TAVR? Presenter: Kendra Grubb November 04, 2021
News Conference News TCT 2021 Fracture Improves Gradients in ViV TAVI, but Ideal Timing Still Unknown Michael O'Riordan October 07, 2021
Video » Interview PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk November 4, 2021